home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

World Drug Manufacturing Summit 2006

 
  July 18, 2006  
     
 
World Trade Group, Berlin, Germany
13th - 14th November 2006


The drug manufacturing industry is under increasing pressure to innovate and streamline manufacturing operations, reduce costs and time to market whilst meeting compliance and regulatory standards.

The WDM Summit addresses these issues and allows delegates to take a complete snapshot of the drug manufacturing industry today

Benefits of attending the World Drug Manufacturing Summit 2006:
- PAT & QbD – learn from leading companies about their experiences in integration
- GMPs – avoid the most common regulatory deficiencies in manufacturing
- Low cost competition – learn how to compete with low cost countries
- Counterfeit drugs – hear about the latest movements in this field
- Manufacturing for a potential pandemic – lessons to be learned from large scale projects
- Biopharmaceutical manufacturing – increasing yield through process improvement

Who should attend WDM Summit 2006?

Vice Presidents, Directors, Heads of, Managing Directors and Managers responsible for:

- Manufacturing
- Quality
- Compliance
- Supply Chain
- Security
- Process Management

Pre-Arranged Meetings

This is a dedicated session which allows you to take up to seven pre-scheduled business meetings with leading supplier companies. You will meet with people who you have chosen and who have expressed a strong interest in meeting with you. Selections are made prior to the event using the event catalogue which contains detailed information on all participants including short and long-term business objectives. Pre-arranged meetings ensure your networking time is spent productively - maximising your chance of doing real business at the event

 
 
Organized by: World Trade Group London
Invited Speakers: - Dr Michael Spink
Executive Director, Regional Manufacturing & Legacy Products
Eli Lilly
- Andrew Jackson
Executive Director & Deputy Head of Global Corporate Security
Novartis International AG
- Christopher Ames
Director, Validation Engineering
F.Hoffman-La Roche
- Richard Andrews
Operations Manager
MHRA
- Dr Wim Mens
Vice President, Production
Organon
- Dr David Broad
Vice President & General Manager, Oceanside Product Operations
Genentech
- Thomas Reith
Director, Electronic Management Execution Systems
Boehringer-Ingelheim
- Christer Karlsson
gPARD Leader Product and Process Robustness
AstraZeneca
- Maria Wingren
Project Manager
Ferring AB
 
Deadline for Abstracts: none
 
Registration: http://www.wdmsummit.com/delegate_reg1.asp
E-mail: Lisa.Wulf@worldtradeco.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.